<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523725/" ref="ordinalpos=496&amp;ncbi_uid=4486478&amp;link_uid=PMC3523725" image-link="/pmc/articles/PMC3523725/figure/F7/" class="imagepopup">Figure 7. A schematic diagram of LRP1-dependent vascular calcification.  From: PPAR? COUNTERACTS LRP1-INDUCED VASCULAR CALCIFICATION BY INHIBITING A WNT5A <span class="highlight" style="background-color:">SIGNALING</span> <span class="highlight" style="background-color:">PATHWAY</span>. </a></div><br /><div class="p4l_captionBody">When mice are fed an atherogenic diet, vascular calcification is induced if LRP1 is expressed in vSMCs. LRP1 positively regulates a Wnt5a signaling pathway that activates chondrogenic-specific genes in the vascular wall. PPARÎ³ and its target sFRP2, by counteracting the prochondrogenic Wnt5 pathway, protect against vascular calcification. Conversely, in the absence of LRP1, Wnt5a signaling is inhibited, an event that promotes intracellular cholesterol accumulation and foam cell development.</div></div>